Here is the latest shareholding Pattern of INDO BORAX. For more details, see the INDO BORAX financial fact sheet and INDO BORAX share price.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 54.19 | 53.78 | 53.78 | 53.00 | 52.07 | 52.07 | 52.07 | 50.80 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 54.19 | 53.78 | 53.78 | 53.00 | 52.07 | 52.07 | 52.07 | 50.80 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.06 | 0.09 | 0.11 | 0.06 | 0.22 | 0.01 | 0.03 | 0.10 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.06 | 0.09 | 0.11 | 0.06 | 0.22 | 0.01 | 0.03 | 0.10 | |
Bodies Corporate | % | 1.52 | 1.50 | 1.54 | 1.56 | 1.59 | 1.47 | 1.75 | 2.21 | |
Individuals | % | 32.66 | 33.03 | 32.33 | 33.41 | 34.49 | 34.92 | 34.45 | 35.08 | |
NRIs/OCBs | % | 2.19 | 2.12 | 2.02 | 2.06 | 2.17 | 2.20 | 2.22 | 2.19 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 9.39 | 9.48 | 10.22 | 9.91 | 9.46 | 9.33 | 9.48 | 9.62 | |
Total Non-Institution | % | 45.76 | 46.13 | 46.11 | 46.94 | 47.71 | 47.92 | 47.90 | 49.10 | |
Total Public | % | 46.00 | 46.00 | 46.00 | 47.00 | 48.00 | 48.00 | 48.00 | 49.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Chemicals & Pesticides Company Shareholding Pattern: UPL PIDILITE INDUSTRIES HIMADRI SPECIALITY CHEMICAL TATA CHEMICALS GFL
Asian share benchmarks fell on Thursday as markets digested the implications of policymakers in major economies preferring to take patient approach to monetary easing amid sticky inflation.